Voloridge Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59,605
Closed -$1.67M 1400
2023
Q2
$1.67M Sell
59,605
-69,545
-54% -$1.73M 0.01% 1018
2023
Q1
$2.88M Buy
129,150
+110,737
+601% +$2.9M 0.01% 862
2022
Q4
$489K Sell
18,413
-100,695
-85% -$3.29M ﹤0.01% 1278
2022
Q3
$3.38M Sell
119,108
-36,626
-24% -$942K 0.02% 793
2022
Q2
$3.24M Buy
155,734
+112,720
+262% +$2.11M 0.02% 841
2022
Q1
$932K Buy
+43,014
New +$933K 0.01% 1147

Other funds holding CCRN

Voloridge Investment Management's CCRN Position: Q3 2023 in Review

Voloridge Investment Management sold out of Cross Country Healthcare (CCRN) in Q3 2023, closing a stake of 59,605 shares — an estimated $1.67M sold.

Voloridge Investment Management first reported a position in CCRN in Q1 2022 and held it in 6 quarters. The position peaked at $3.38M in Q3 2022. 189 funds tracked by Wall St. Rank hold CCRN as of Q3 2023.

  • Voloridge Investment Management reported no remaining Cross Country Healthcare position as of Q3 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 59,605 Cross Country Healthcare shares in Q3 2023, an estimated $1.67M.
  • Voloridge Investment Management first reported a position in Cross Country Healthcare in Q1 2022 and held it in 6 quarters.
  • Voloridge Investment Management's Cross Country Healthcare position peaked at $3.38M in Q3 2022.
  • 189 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.